Lataa...
EZH2 overexpression is associated with poor prognosis in patients with glioma
Previous studies have investigated the prognostic value of enhancer of zeste homolog 2 (EZH2) expression in patients with glioma but conclude contradictory results. We aimed to comprehensively evaluate the prognostic role of EZH2 in glioma by meta-analysis. The databases of PubMed, Embase and Web of...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352178/ https://ncbi.nlm.nih.gov/pubmed/27880940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13478 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|